Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
<h4>Background</h4>Pneumonia is a common and severe complication of abdominal surgery, it is associated with increased length of hospital stay, healthcare costs, and mortality. Further, pulmonary complication rates have risen during the SARS-CoV-2 pandemic. This study explored the potent...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2a0a006881b94a1d890ea3fe6aaef264 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2a0a006881b94a1d890ea3fe6aaef264 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2a0a006881b94a1d890ea3fe6aaef2642021-11-25T05:54:13ZPreliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.1932-620310.1371/journal.pone.0254698https://doaj.org/article/2a0a006881b94a1d890ea3fe6aaef2642021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254698https://doaj.org/toc/1932-6203<h4>Background</h4>Pneumonia is a common and severe complication of abdominal surgery, it is associated with increased length of hospital stay, healthcare costs, and mortality. Further, pulmonary complication rates have risen during the SARS-CoV-2 pandemic. This study explored the potential cost-effectiveness of administering preoperative chlorhexidine mouthwash versus no-mouthwash at reducing postoperative pneumonia among abdominal surgery patients.<h4>Methods</h4>A decision analytic model taking the South African healthcare provider perspective was constructed to compare costs and benefits of mouthwash versus no-mouthwash-surgery at 30 days after abdominal surgery. We assumed two scenarios: (i) the absence of COVID-19; (ii) the presence of COVID-19. Input parameters were collected from published literature including prospective cohort studies and expert opinion. Effectiveness was measured as proportion of pneumonia patients. Deterministic and probabilistic sensitivity analyses were performed to assess the impact of parameter uncertainties. The results of the probabilistic sensitivity analysis were presented using cost-effectiveness planes and cost-effectiveness acceptability curves.<h4>Results</h4>In the absence of COVID-19, mouthwash had lower average costs compared to no-mouthwash-surgery, $3,675 (R 63,770) versus $3,958 (R 68,683), and lower proportion of pneumonia patients, 0.029 versus 0.042 (dominance of mouthwash intervention). In the presence of COVID-19, the increase in pneumonia rate due to COVID-19, made mouthwash more dominant as it was more beneficial to reduce pneumonia patients through administering mouthwash. The cost-effectiveness acceptability curves shown that mouthwash surgery is likely to be cost-effective between $0 (R0) and $15,000 (R 260,220) willingness to pay thresholds.<h4>Conclusions</h4>Both the absence and presence of SARS-CoV-2, mouthwash is likely to be cost saving intervention for reducing pneumonia after abdominal surgery. However, the available evidence for the effectiveness of mouthwash was extrapolated from cardiac surgery; there is now an urgent need for a robust clinical trial on the intervention on non-cardiac surgery.Mwayi KachapilaAdesoji O AdemuyiwaBruce M BiccardDhruva N GhoshJames GlasbeyMark MonahanRachel MooreDion G MortonRaymond OppongRupert PearseTracy E RobertsNIHR Global Health Research Unit on Global SurgeryASOS InvestigatorsSTARSurg CollaborativePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 8, p e0254698 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Mwayi Kachapila Adesoji O Ademuyiwa Bruce M Biccard Dhruva N Ghosh James Glasbey Mark Monahan Rachel Moore Dion G Morton Raymond Oppong Rupert Pearse Tracy E Roberts NIHR Global Health Research Unit on Global Surgery ASOS Investigators STARSurg Collaborative Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa. |
description |
<h4>Background</h4>Pneumonia is a common and severe complication of abdominal surgery, it is associated with increased length of hospital stay, healthcare costs, and mortality. Further, pulmonary complication rates have risen during the SARS-CoV-2 pandemic. This study explored the potential cost-effectiveness of administering preoperative chlorhexidine mouthwash versus no-mouthwash at reducing postoperative pneumonia among abdominal surgery patients.<h4>Methods</h4>A decision analytic model taking the South African healthcare provider perspective was constructed to compare costs and benefits of mouthwash versus no-mouthwash-surgery at 30 days after abdominal surgery. We assumed two scenarios: (i) the absence of COVID-19; (ii) the presence of COVID-19. Input parameters were collected from published literature including prospective cohort studies and expert opinion. Effectiveness was measured as proportion of pneumonia patients. Deterministic and probabilistic sensitivity analyses were performed to assess the impact of parameter uncertainties. The results of the probabilistic sensitivity analysis were presented using cost-effectiveness planes and cost-effectiveness acceptability curves.<h4>Results</h4>In the absence of COVID-19, mouthwash had lower average costs compared to no-mouthwash-surgery, $3,675 (R 63,770) versus $3,958 (R 68,683), and lower proportion of pneumonia patients, 0.029 versus 0.042 (dominance of mouthwash intervention). In the presence of COVID-19, the increase in pneumonia rate due to COVID-19, made mouthwash more dominant as it was more beneficial to reduce pneumonia patients through administering mouthwash. The cost-effectiveness acceptability curves shown that mouthwash surgery is likely to be cost-effective between $0 (R0) and $15,000 (R 260,220) willingness to pay thresholds.<h4>Conclusions</h4>Both the absence and presence of SARS-CoV-2, mouthwash is likely to be cost saving intervention for reducing pneumonia after abdominal surgery. However, the available evidence for the effectiveness of mouthwash was extrapolated from cardiac surgery; there is now an urgent need for a robust clinical trial on the intervention on non-cardiac surgery. |
format |
article |
author |
Mwayi Kachapila Adesoji O Ademuyiwa Bruce M Biccard Dhruva N Ghosh James Glasbey Mark Monahan Rachel Moore Dion G Morton Raymond Oppong Rupert Pearse Tracy E Roberts NIHR Global Health Research Unit on Global Surgery ASOS Investigators STARSurg Collaborative |
author_facet |
Mwayi Kachapila Adesoji O Ademuyiwa Bruce M Biccard Dhruva N Ghosh James Glasbey Mark Monahan Rachel Moore Dion G Morton Raymond Oppong Rupert Pearse Tracy E Roberts NIHR Global Health Research Unit on Global Surgery ASOS Investigators STARSurg Collaborative |
author_sort |
Mwayi Kachapila |
title |
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa. |
title_short |
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa. |
title_full |
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa. |
title_fullStr |
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa. |
title_full_unstemmed |
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa. |
title_sort |
preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in south africa. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/2a0a006881b94a1d890ea3fe6aaef264 |
work_keys_str_mv |
AT mwayikachapila preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT adesojioademuyiwa preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT brucembiccard preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT dhruvanghosh preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT jamesglasbey preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT markmonahan preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT rachelmoore preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT diongmorton preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT raymondoppong preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT rupertpearse preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT tracyeroberts preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT nihrglobalhealthresearchunitonglobalsurgery preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT asosinvestigators preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica AT starsurgcollaborative preliminarymodelassessingthecosteffectivenessofpreoperativechlorhexidinemouthwashatreducingpostoperativepneumoniaamongabdominalsurgerypatientsinsouthafrica |
_version_ |
1718414389213659136 |